It is essential for researchers to keep abreast of the work being done by colleagues in a variety of disciplines. To facilitate this, the UCLA CFAR sponsors a weekly conference featuring presentations made by researchers working in both basic and translational sciences, clinical therapeutics and biomedical prevention. The topics covered include, among many others, novel therapeutics, vaccines, stem-cell research, aging, and viral pathogenesis.
|Mar 20||Shi Yuan (Sun)/Mark Grossman (Yang)|
|Mar 27||Gaju Suryavanshi (Chen)/ Yinong Zhang (Zhou)|
|Apr 03||Nisar Farhat (Wu)/Joseph Kim (Yang)|
|Apr 10||Nicolas Webb (Aldrovandi)/Jeff Dock (Bryson)|
|Apr 17||Marta Epeldegui /Christian Hofmann (Yang)|
|Apr 24||Tian-Hao Zhang (Sun) / Virology&Gene Therapy (Brian Truong)|
|May 08||Melody Li|
|May 22||Ke Ding (Zhou)/ Virology&Gene Therapy (David Gray)|
|Jun 05||Gurpreet Brar (Wu)/ Virology&Gene Therapy (Laura Martinez)|
If you are unable to present at the lab meeting for which you are responsible (barring emergencies), please make every effort to arrange for another Lab Meeting Presenter to take your place. After you have changed your schedule, please contact Ting-Ting at x72218 or email@example.com to inform her of any changes you have made at least one week prior to your scheduled meeting.
The Grand Rounds lecture series consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty. The aims of the program are to highlight important developments in AIDS-related research, encourage collaborations between UCLA investigators and invited speakers, interest young investigators in AIDS research, and provide information about new findings and funding opportunities.
|DATE||PRESENTER||POSITION/AFFILIATION||TITLE OF LECTURE/SUBJECT AREA||ROOM NUMBER|
|10/13/17||Assistant Professor, Division of Infectious Diseases & Global Public Health
University of California, San Diego
|“The prevention of injection drug use: Emerging responses"||13-105 CHS|
William Watt Kerr Professor of Clinical Medicine
|“HIV, Inflammation, and CVD"||13-105 CHS|
|12/08/17||Professor of Pathology & Laboratory Medicine, Emory University||“It’s not all about the immune response - how the genotype of the transmitted-founder virus defines HIV disease progression”||13-105 CHS|
|03/02/18||Human Sciences Research Council, South Africa, University of Cape Town, South Africa||“The dilemmas of clinical trial participant recruitment in African countries: Some lessons from South Africa"||A2-342 MDCC|
|03/06/18||Associate Professor of Internal Medicine, Yale University||“Host Genetic Control of HIV"||BSRB 154|
|04/13/18||Dr. Hortensia Amaro||Dean's Professor, Suzanne Dworak-Peck School of Social Work and Professor, Department of Preventive Medicine, USC Keck School of Medicine||“Promise and Fallacy: HIV/AIDS Prevention"||13-105 CHS|
|05/11/18||Professor, Division of Infectious Diseases, University of Pittsburgh School of Medicine||“HIV CURE: Hype or hope?"||13-105 CHS|
|06/22/18||Distinguished Professor and Chair, Molecular Microbiology and Immunology, Fletcher Jones Foundation Chair in Molecular Microbiology and Immunology, Keck School of Medicine of USC||“Immunopathogenesis of two emerging viruses: Zika virus and SFTS virus"||BSRB 154|